| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Voyager Therapeutics, Inc. (VYGR) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. VYGR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.1K | $2.01M | - | |
| COO | 199.7K | $828.9K | - | |
| Other | 183.9K | $763.2K | - | |
| CFO | 151.4K | $628.4K | - | |
| Other | 145.7K | $604.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Hesslein Robert W.49 | Senior VP &General Counsel | Sell | 3,297 | $7.45 | $24,562.65 | -3.0% | +65.1% | +1.6% | |
| Feb 17, 2023 | Carter Todd Alfred69 | Chief Scientific Officer | Sell | 738 | $7.45 | $5,498.10 | -1.1% | +65.1% | +1.6% | |
| Feb 13, 2023 | Carter Todd Alfred69 | Chief Scientific Officer | Sell | 797 | $7.67 | $6,112.99 | -2.3% | +33.2% | -8.5% | |
| Feb 13, 2023 | Hesslein Robert W.49 | Senior VP &General Counsel | Sell | 2,868 | $7.67 | $21,997.56 | -2.5% | +33.2% | -8.5% | |
| Feb 1, 2023 | Third Rock Ventures Iii, L.P.65 | 10% Owner | Sell | 388,642 | $9.23 | $3,587,443.44 | -2.6% | -25.9% | -19.2% | |
| Jan 27, 2023 | Third Rock Ventures Iii, L.P.65 | 10% Owner | Sell | 50,000 | $9.02 | $451,000.00 | -1.0% | -19.2% | -16.6% | |
| Jan 25, 2023 | Third Rock Ventures Iii, L.P.65 | 10% Owner | Sell | 150,000 | $9.25 | $1,388,000.00 | -1.4% | -17.3% | -16.3% | |
| Jan 23, 2023 | Third Rock Ventures Iii, L.P.65 | 10% Owner | Sell | 155,000 | $9.12 | $1,413,300.00 | -1.4% | -15.9% | -17.4% | |
| Jan 17, 2023 | Hesslein Robert W.49 | Senior VP &General Counsel | Sell | 2,188 | $9.85 | $21,549.00 | -1.0% | -14.0% | -20.7% | |
| Jan 17, 2023 | Carter Todd Alfred69 | Chief Scientific Officer | Sell | 1,106 | $9.85 | $10,892.42 | -1.5% | -14.0% | -20.7% |